We're Delivering the Promise of Healthier Lives.
Company News
CURE announces plans to acquire Sera Labs, a leader in the CBD industry
Read More
We're NSF-Certified
CURE Pharmaceutical Receives NSF’s cGMP Certification for Dietary Supplements
Read More

We are committed to developing new ways to deliver and experience medicines, supplements, and cosmetics.

We are a vertically-integrated drug delivery and development company with a proprietary formulation and delivery platform called CUREform™.

CUREform™ combines the right dosage form with the right formulation for optimal delivery of therapeutic actives. The CUREform™ platform includes our signature oral dissolvable film, CUREfilm®, a patented oral thin film formulation that makes medications easier to take, more efficacious, with improved tolerability and fewer side effects.

We are also pioneering a novel chewable drug delivery system, CUREpods™ capable of high dose actives and enhanced solubility and absorption. These innovative dosage forms are powered by molecular encapsulation techniques, which together, provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients.

Read more about CUREform

Work With Us

Contact Us
We develop and manufacture our CUREform™ products in Oxnard, CA for the dietary supplement, cosmetic and pharmaceutical industries. Our 25,000 manufacturing facility is registered with the United States Food and Drug Administration (FDA) where we comply with Current Good Manufacturing Practice regulations as enforced by the FDA. We also hold the NSF® cGMP certification for manufacturing dietary supplements. Contact us to learn more about how we can help you with more efficient drug delivery technology in nutraceuticals, pharmaceutical medicines, and cosmetics.

Cannabinoid Delivery

We specialize in the formulation and delivery of cannabinoids and terpenes from transdermal and transmucosal drugs to topical and oral consumer products. Our manufacturing facility is registered with the United States Drug Enforcement Administration (DEA) to manufacture Schedule 1 pharmaceutical cannabinoids.

GET POWERED BY CURE

Partner With Us

Get Started